Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Claire S. Whyte, Gael B. Morrow, Joanne L. Mitchell, Pratima Chowdary, Nicola J. Mutch*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

201 Citations (Scopus)
7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19'. Together they form a unique fingerprint.

Medicine & Life Sciences